Vitrafy Life Sciences Limited engages in the research, development, and commercialization of cryopreservation solutions in Australia. The company offers smart devices, such as smart cryopreservation, smart thawing, and smart packaging devices. It also provides a software platform, which controls, trace, tracks, and monitors quality of cryopreserved biomaterials under the LifeChain brand. The company’s cryopreservation technology is used various applications, such as blood platelets, cell and gene therapies, and aquaculture and bovine breeding programs. Vitrafy Life Sciences Limited was incorporated in 2017 and is based in Melbourne, Australia.
Metrics to compare | VFY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVFYPeersSector | |
---|---|---|---|---|
P/E Ratio | −2.5x | −1.6x | −0.6x | |
PEG Ratio | −0.03 | −0.01 | 0.00 | |
Price/Book | 2.8x | 1.6x | 2.6x | |
Price / LTM Sales | 77.4x | 3.9x | 3.3x | |
Upside (Analyst Target) | 73.7% | 112.1% | 38.7% | |
Fair Value Upside | Unlock | 12.5% | 5.1% | Unlock |